One such innovative treatment we provide is Ozempic, a GLP-1 receptor agonist initially developed to help individuals with Type 2 diabetes manage their blood sugar
GLP-1 RAs are built on slightly different active ingredients, depending on which brand you get, and semaglutide is the active ingredient for Ozempic and Wegovy
Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes
If you're considering compounded semaglutide or tirzepatide, do you understand that these are not the same as FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound, and that compounded medications have not undergone the same level of pre-market FDA review
It tends to be more common with the medication in general, due to side effects such as vomiting and diarrhea
By this point, most protocols have titrated to 4 mg or are approaching 8 mg